Combinations of drugs in the Treatment of Obesity

Bruno Halpern¹, Eduardo S L Oliveira², André M Faria³, Alfredo Halpern⁴, Maria Edna de Melo⁵, Cintia Cercato⁶, Marcio C Mancini⁷

Affiliations

¹ Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. brunohalpern@hotmail.com.
² Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. eduardolorena@uol.com.br.
³ Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. andremfaria@hotmail.com.
⁴ Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. alfredo.halpern@netpoint.com.br.
⁵ Laboratory of Carbohydrates and Radioimuneassay/LIM-18, Faculty of Medicine, University of São Paulo, Av. Dr Arnaldo, 455 01246-903 - São Paulo, SP, Brazil. medna@usp.br.
⁶ Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. ccercato@netpoint.com.br.
⁷ Laboratory of Carbohydrates and Radioimuneassay/LIM-18, Faculty of Medicine, University of São Paulo, Av. Dr Arnaldo, 455 01246-903 - São Paulo, SP, Brazil. mmancini@usp.br.

PMID: 27713360
PMCID: PMC4033931
DOI: 10.3390/ph3082398

Review

Combinations of drugs in the Treatment of Obesity

Bruno Halpern et al. Pharmaceuticals (Basel). 2010.

. 2010 Jul 27;3(8):2398-2415.

doi: 10.3390/ph3082398.

Authors

Bruno Halpern¹, Eduardo S L Oliveira², André M Faria³, Alfredo Halpern⁴, Maria Edna de Melo⁵, Cintia Cercato⁶, Marcio C Mancini⁷

Affiliations

¹ Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. brunohalpern@hotmail.com.
² Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. eduardolorena@uol.com.br.
³ Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. andremfaria@hotmail.com.
⁴ Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. alfredo.halpern@netpoint.com.br.
⁵ Laboratory of Carbohydrates and Radioimuneassay/LIM-18, Faculty of Medicine, University of São Paulo, Av. Dr Arnaldo, 455 01246-903 - São Paulo, SP, Brazil. medna@usp.br.
⁶ Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil. ccercato@netpoint.com.br.
⁷ Laboratory of Carbohydrates and Radioimuneassay/LIM-18, Faculty of Medicine, University of São Paulo, Av. Dr Arnaldo, 455 01246-903 - São Paulo, SP, Brazil. mmancini@usp.br.

PMID: 27713360
PMCID: PMC4033931
DOI: 10.3390/ph3082398

Abstract

Obesity is a chronic disease associated with excess morbidity and mortality. Clinical treatment, however, currently offers disappointing results, with very high rates of weight loss failure or weight regain cycles, and only two drugs (orlistat and sibutramine) approved for long-term use. Drugs combinations can be an option for its treatment but, although widely used in clinical practice, very few data are available in literature for its validation. Our review focuses on the rationale for their use, with advantages and disadvantages; on combinations often used, with or without studies; and on new perspectives of combinations being studied mainly by the pharmaceutical industry.

Keywords: 5-hydroxytryptophan; antidepressants; bupropion; caffeine; carbidopa; drug combination; ephedrine; fenfluramine; glucagon-like peptide-1; leptin; metformin; metreleptin; naltrexone; noradrenergic drugs; orlistat; peptide YY; phentermine; pramlintide; sibutramine; topiramate; zonisamide.

PubMed Disclaimer

Cited by

PK/PD modeling of 5-hydroxytryptophan (5-HTP) challenge test with cortisol measurement in serum and saliva.
Guan Z, Jacobs G, van Pelt H, Van Gerven JMA, Burggraaf J, Zhao W. Guan Z, et al. Pharmacol Res Perspect. 2020 Apr;8(2):e00574. doi: 10.1002/prp2.574. Pharmacol Res Perspect. 2020. PMID: 32168433 Free PMC article. Clinical Trial.
Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Kwon YJ, Lee H, Nam CM, Chang HJ, Yoon YR, Lee HS, Lee JW. Kwon YJ, et al. Diabetes Metab Syndr Obes. 2021 Mar 2;14:941-950. doi: 10.2147/DMSO.S300342. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33688228 Free PMC article.
Challenges in the care and treatment of patients with extreme obesity.
Stumpf MAM, Mancini MC. Stumpf MAM, et al. Arch Endocrinol Metab. 2024 Jul 18;68:e230335. doi: 10.20945/2359-4292-2023-0335. eCollection 2024. Arch Endocrinol Metab. 2024. PMID: 39420906 Free PMC article. Review.
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.
Lundkvist P, Pereira MJ, Katsogiannos P, Sjöström CD, Johnsson E, Eriksson JW. Lundkvist P, et al. Diabetes Obes Metab. 2017 Sep;19(9):1276-1288. doi: 10.1111/dom.12954. Epub 2017 May 31. Diabetes Obes Metab. 2017. PMID: 28345814 Free PMC article. Clinical Trial.
Pharmacotherapy for obesity: moving towards efficacy improvement.
Coutinho W, Halpern B. Coutinho W, et al. Diabetol Metab Syndr. 2024 Jan 3;16(1):6. doi: 10.1186/s13098-023-01233-4. Diabetol Metab Syndr. 2024. PMID: 38172940 Free PMC article.

See all "Cited by" articles

References

1. Global Strategy on Diet, Physical Activity and Health. World Health Organization; Geneva, Switzerland: 2010. [(accessed on 12 June 2010)]. Available online: http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/pr...
1. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause specific excess deaths associated with underweight, overweight and obesity. J. Am. Med. Assoc. 2007;298:2028–2037. - PubMed
1. Douketis J.D., Macie C., Thabane L., Williamson D.F. Systematic review of long-term weight loss studies in obese adults: Clinical significance and applicability to clinical practice. Int. J. Obes. (Lond.) 2005;29:1153–1167. - PubMed
1. Rucker D., Padwal R., Li S.K., Curioni C., Lau D.C.W. Long term pharmacotherapy for obesity and overweight: Updated meta-analysis. Br. Med. J. 2007;335:1194–1199. - PMC - PubMed
1. Bray G.A. Lifestyle and pharmacological approaches to weight loss: Efficacy and safety. J. Clin. Endocrinol. Metab. 2008;93:S81–S88. - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Combinations of drugs in the Treatment of Obesity

Affiliations

Combinations of drugs in the Treatment of Obesity

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources